00059sek
-4,8 %
Date:2025-04-03Time:12:35:27Latest report:Q2-2024List:First NorthTicker:QUIA
Market Cap:13 msekEnterprise Value:10 msekNet Sales:2,36 msekEarnings:-13,9 msekEmployees:0ISIN:SE0020678159

Ratios

10-year key figure history for QuiaPEG Pharmaceuticals turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for QuiaPEG Pharmaceuticals with index and moving average MA50 and MA200.

Stockprice:0,0059
MA50:0,01
MA200:0,02
Price/MA200:-75,1 %
RSI (14):60,8
Price/MA50:8,0 %

Description

QUIA PHARMA AB is a development company for pharmaceuticals based on a patented drug delivery platform, Uni-Qleaver. The company develops improved and patentable forms of drugs under development or already approved by pharmaceutical authorities. These refined and enhanced forms of medicine are based on the Company's exceptional and patented technology platform. In addition to this, the Company offers multinational sales of omega-3, astaxin and collagen through Amazon.

Pharmaceuticals